Abstract:Background: 3β-Hydroxysteroid dehydrogenase (3β-HSD) deficiency is a rare cause of congenital adrenal hyperplasia (CAH) caused by inactivating mutations in the HSD3B2 gene. Patient and Methods: We report the molecular and structural analysis of the HSD3B2 gene in a 46,XY child born to apparently nonconsanguineous parents and presenting ambiguous genitalia and salt wasting. The steroid profile showed elevated concentrations of 17-hydroxyprogesterone, androstenedione, ACTH and plasma renin, but normal values of … Show more
“…Disorders of androgen synthesis include luteinizing hormone receptor defects and defects in the testicular steroidogenesis pathway ( Table 2) Among all forms of 46, XY DSD, the genetic causes are clear for those presenting with enzyme deficiencies of 'classic' androgen biosynthesis pathways, including 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) or 3β-hydroxysteroid dehydrogenase type 2 (3β-HSD2) deficiency. Whilst the deficit of 17β-HSD3 may interfere only with androgen production and more often is detected because of virilization at puberty, 3β-HSD2 may affect all steroidogenic pathways and, therefore, results in severe salt-wasting and non-salt wasting forms of CAH and ambiguous genitalia in affected boys [106,107]. Over 45 causative mutations have been reported in HSD17B3 and the prevalence has been reported about 1 per 150 000 [108].…”
Section: Disorders Of Androgen Synthesismentioning
Considering that children and adults with DSD may be at risk of several comorbidities a clear aetiological diagnosis will guide further management. To date, a firm diagnosis is not reached in over half of the cases of 46,XY DSD. Whilst it is likely that improved diagnostic resources will bridge this gap in the future, the next challenge to the clinical community will be to show that such advances will result in an improvement in clinical care.
“…Disorders of androgen synthesis include luteinizing hormone receptor defects and defects in the testicular steroidogenesis pathway ( Table 2) Among all forms of 46, XY DSD, the genetic causes are clear for those presenting with enzyme deficiencies of 'classic' androgen biosynthesis pathways, including 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) or 3β-hydroxysteroid dehydrogenase type 2 (3β-HSD2) deficiency. Whilst the deficit of 17β-HSD3 may interfere only with androgen production and more often is detected because of virilization at puberty, 3β-HSD2 may affect all steroidogenic pathways and, therefore, results in severe salt-wasting and non-salt wasting forms of CAH and ambiguous genitalia in affected boys [106,107]. Over 45 causative mutations have been reported in HSD17B3 and the prevalence has been reported about 1 per 150 000 [108].…”
Section: Disorders Of Androgen Synthesismentioning
Considering that children and adults with DSD may be at risk of several comorbidities a clear aetiological diagnosis will guide further management. To date, a firm diagnosis is not reached in over half of the cases of 46,XY DSD. Whilst it is likely that improved diagnostic resources will bridge this gap in the future, the next challenge to the clinical community will be to show that such advances will result in an improvement in clinical care.
We aim to review data on 3beta-hydroxysteroid dehydrogenase type II (3βHSD2) deficiency. We identified 30 studies within the last decade on PubMed: 1 longitudinal study (N = 14), 2 cross-sectional studies, 1 retrospective study (N = 16), and 26 case reports (total: 98 individuals). Regarding geographic area: Algeria (N = 14), Turkey (N = 31), China (2 case reports), Morocco (2 sisters), Anatolia (6 cases), and Italy (N = 1). Patients’ age varied from first days of life to puberty; the oldest was of 34 y. Majority forms displayed were salt-wasting (SW); some associated disorders of sexual development (DSD) were attendant also—mostly 46,XY males and mild virilisation in some 46,XX females. SW pushed forward an early diagnosis due to severity of SW crisis. The clinical spectrum goes to: premature puberty (80%); 9 with testicular adrenal rest tumours (TARTs); one female with ovarian adrenal rest tumours (OARTs), and some cases with adrenal hyperplasia; cardio-metabolic complications, including iatrogenic Cushing’ syndrome. More incidental (unusual) associations include: 1 subject with Barter syndrome, 1 Addison’s disease, 2 subjects of Klinefelter syndrome (47,XXY/46,XX, respective 47,XXY). Neonatal screening for 21OHD was the scenario of detection in some cases; 17OHP might be elevated due to peripheral production (pitfall for misdiagnosis of 21OHD). An ACTH stimulation test was used in 2 studies. Liquid chromatography tandem–mass spectrometry unequivocally sustains the diagnostic by expressing high baseline 17OH-pregnenolone to cortisol ratio as well as 11-oxyandrogen levels. HSD3B2 gene sequencing was provided in 26 articles; around 20 mutations were described as “novel pathogenic mutation” (frameshift, missense or nonsense); many subjects had a consanguineous background. The current COVID-19 pandemic showed that CAH-associated chronic adrenal insufficiency is at higher risk. Non-adherence to hormonal replacement contributed to TARTs growth, thus making them surgery candidates. To our knowledge, this is the largest study on published cases strictly concerning 3βHSD2 deficiency according to our methodology. Adequate case management underlines the recent shift from evidence-based medicine to individualized (patient-oriented) medicine, this approach being particularly applicable in this exceptional and challenging disorder.
“…The enzyme 3βHSD2 is encoded by gene HSD3β2, which is located on chromosome 1. Mutations are mainly represented by missense and nonsense mutations, whereas deletions and insertions are less frequent (Bizzarri et al 2016). These mutations mainly affect protein stability, leading to complete or nearly complete enzyme inactivity.…”
Section: Bhsd2-d Cahmentioning
confidence: 99%
“…These mutations mainly affect protein stability, leading to complete or nearly complete enzyme inactivity. However, different mutations, including 956delT, affecting substratebinding region (Simard et al 2005;Bizzarri et al 2016), and uniparental isodisomy of chromosome 1, have been rarely reported (Panzer et al 2017).…”
Genetic forms of primary adrenal insufficiency (AI) present clinical heterogeneity, variable modes of inheritance, and association with several clinical pictures. Congenital adrenal hyperplasia (CAH) comprises a wide group of autosomal recessive enzymatic disorders, impairing glucocorticoid, mineralocorticoid, and/ or androgen biosynthesis. The most frequent form of CAH is due to 21-hydroxylase deficiency. Adrenoleukodystrophy is an X-linked progressive metabolic disorder, characterized by very long chain fatty acids accumulation with cytotoxic effects on adrenal and neural cells. Adrenal hypoplasia congenita is an X-linked
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.